gabapentin

FDA Drug Profile — Neurontin, GABAPENTIN, Gabapentin, gabapentin, Gralise

gabapentin is listed in the FDA National Drug Code directory with 121 NDC codes, marketed under brand names including Neurontin, GABAPENTIN, Gabapentin. Available dosage forms: capsule, tablet, tablet, film coated, solution, suspension.

Drug details

Generic Name
gabapentin
Brand Names
Neurontin, GABAPENTIN, Gabapentin, gabapentin, Gralise
Application Number
NDA020235
Sponsor
Parke-Davis Div Of Pfizer Inc
NDC Codes
121
Dosage Forms
CAPSULE, TABLET, TABLET, FILM COATED, SOLUTION, SUSPENSION
Routes
ORAL
Active Ingredients
GABAPENTIN

Indications and Usage

1 INDICATIONS AND USAGE Gabapentin Capsules are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin capsules are indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.